Skip to Content
Søk Menu

EADV 2024 – Still Unanswered Questions about Psoriasis and Psoriasis Treatment

In this MEDtalk Lone Skov, professor in dermatology and consultant in dermatology at the Department of Dermatology at Gentofte Hospital present her experiences from the EADV congress in Amsterdam 2024 concerning new data about psoriasis and psoriasis arthritis treatment.
Lone Skov

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Relaterat innehåll

Annarita Antelmi

A Large Proportion of Patients with Prurigo Nodularis Receive Several Different Treatment Combinations and Switches and a High Number of Healthcare Visits

/ Annarita Antelmi
EADV24 Play the Video 07:01
Viola Ikebudu Adaeze

Diagnostic Challenges for Immunobullous Disorders in Elderly Patients in Lagos

/ Viola Ikebudu Adaeze
EADV24 Play the Video 1:23

Deucravacitinib, A New Oral Option for Patients with Moderate to Severe Psoriasis

/ Sofie Pohl
Psoriasis
Giovanni Damiani

A lot of Factors Increase the Comorbidity at Atopic Dermatitis

/ Giovanni Damiani
Atopisk dermatitEADV24 Play the Video 2:19
Sascha D. W. Stave

Safety Is One of the Main Drivers for Atopic Dermatitis Patient Preferences of Treatment

/ Sascha D. W. Stave
Atopisk dermatitEADV24 Play the Video 07:39
Andrew Blauvelt

LBA: Probably the Best in Class for Treatment of Plaque Psoriasis

/ Andrew Blauvelt
EADV24Psoriasis Play the Video 04:38
Thrasyvoulos Tzellos

AD: Promising Long-Term Safety Profile for Dupilumab in Real-World Data

/ Thrasyvoulos Tzellos
Atopisk dermatitEADV24 Play the Video 02:51
Christopher Willy Schwarz

Non-Medical Switches of Biosimilar in Psoriasis Treatment Appears Safe

/ Christopher Willy Schwarz
EADV24Psoriasis Play the Video 2:45
Katrine Elisabeth Karmisholt

High-Intensity Focused Ultrasound Reduced/Eliminated Tumors in 76% of Patients with Cutaneous Neurofibromas

/ Katrine Elisabeth Karmisholt
EADV24 Play the Video 5:14
Back to top